Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma. | BMC Cancer | 2022 | 35477379 | PubTator, text mining | PubMed |
| Association of vitamin K with cognitive decline and neuropathology in community-dwelling older persons. | Alzheimers Dement (N Y) | 2022 | 35475263 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Tumor Immune Microenvironment Characteristics for the Prognostic Prediction and Immunotherapy of Oral Squamous Cell Carcinoma. | Front Genet | 2022 | 35464860 | PubTator, text mining | PubMed |
| Persistent Lung Injury and Prothrombotic State in Long COVID. | Front Immunol | 2022 | 35464473 | PubTator, text mining | PubMed |
| Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance. | Front Oncol | 2022 | 35463360 | PubTator, text mining | PubMed |
| Microarray dataset supporting a role for ATF4 in isoginkgetin-induced gene expression in HCT116 cells. | Data Brief | 2022 | 35463055 | PubTator, text mining | PubMed |
| Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder. | Front Pharmacol | 2022 | 35462908 | PubTator, text mining | PubMed |
| AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer. | BMC Cancer | 2022 | 35461210 | PubTator, text mining | PubMed |
| Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). | Molecules | 2022 | 35458687 | PubTator, text mining | PubMed |
| Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach. | Genes (Basel) | 2022 | 35456421 | PubTator, text mining | PubMed |
| Analysis of Long Non-Coding RNA (lncRNA) uc.38 and uc.63 Expression in Breast Carcinoma Patients. | Genes (Basel) | 2022 | 35456414 | PubTator, text mining | PubMed |
| How Pyroptosis Contributes to Inflammation and Fibroblast-Macrophage Cross-Talk in Rheumatoid Arthritis. | Cells | 2022 | 35455985 | PubTator, text mining | PubMed |
| Acquired Mechanisms of Resistance to Osimertinib-The Next Challenge. | Cancers (Basel) | 2022 | 35454838 | PubTator, text mining | PubMed |
| Darling: A Web Application for Detecting Disease-Related Biomedical Entity Associations with Literature Mining. | Biomolecules | 2022 | 35454109 | PubTator, text mining | PubMed |
| Commonly Prescribed Anticoagulants Exert Anticancer Effects in Oral Squamous Cell Carcinoma Cells In Vitro. | Biology (Basel) | 2022 | 35453795 | PubTator, text mining | PubMed |
| The Value of Dysregulated LncRNAs on Clinicopathology and Survival in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. | Front Genet | 2022 | 35450214 | PubTator, text mining | PubMed |
| New Therapeutics Targeting Arterial Media Calcification: Friend or Foe for Bone Mineralization? | Metabolites | 2022 | 35448514 | PubTator, text mining | PubMed |
| Inflammation in Cerebral Venous Thrombosis. | Front Immunol | 2022 | 35444662 | PubTator, text mining | PubMed |
| Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19. | Front Pharmacol | 2022 | 35444538 | PubTator, text mining | PubMed |
| Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques. | Immunity | 2022 | 35443157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=51